{"subsection_name": null, "pub_date": "2011-10-25T00:00:00Z", "byline": {"original": "By ANDREW POLLACK", "contributor": "", "person": [{"lastname": "POLLACK", "organization": "", "rank": 1, "role": "reported", "firstname": "Andrew"}]}, "abstract": "Amgen says that it has set aside $780 million to settle various federal and state investigations of whistle-blower lawsuits accusing it of illegal sales and marketing tactics.", "word_count": "630", "print_page": "4", "news_desk": "Business", "snippet": "Lawsuits accused the drug company of illegal sales and marketing tactics.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "subject", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "is_major": "N", "value": "Company Reports", "rank": "2"}, {"name": "subject", "is_major": "N", "value": "Suits and Litigation", "rank": "3"}, {"name": "organizations", "is_major": "Y", "value": "Amgen Inc", "rank": "4"}], "type_of_material": "News", "lead_paragraph": "Lawsuits accused the drug company of illegal sales and marketing tactics.", "web_url": "http://www.nytimes.com/2011/10/25/health/25amgen.html", "section_name": "Health", "headline": {"main": "Amgen to Pay $780 Million to Settle Suits on Its Sales", "print_headline": "Amgen to Pay $780 Million To Settle Suits On Its Sales", "seo": "Amgen to Pay $780 Million to Settle Marketing Accusations"}, "slideshow_credits": null, "_id": "518aa2ffcf28d05efe00193e", "document_type": "article"}